No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity

American Journal of Psychiatry

Volumn 153, Issue 2, 1996, Pages 268-270

  Daniels, J K ^a   Williams, N M ^b   Williams, J ^b   Jones, L A ^b   Cardno, A G ^b   Murphy, K C ^b   Spurlock, G ^b   Riley, B ^b   Scambler, P ^b   Asherson, P ^b   McGuffin, P ^b   Owen, M J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; ENZYME INACTIVATION; FEMALE; FREQUENCY ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 13344284664     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.2.268     Document Type: Article

References (17)

1. McGuffin P, Owen MJ, O'Donovan MC, Thapar A, Gottesman II: Seminars in Psychiatric Genetics. London, Gaskell (Royal College of Psychiatrists), 1994
2. Carlson A: The current state of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988; 1:179-186
3. Axelrod J: Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol Rev 1966; 18:95-113
4. Kety SS: Current biochemical approaches to schizophrenia. N Engl J Med 1967; 276:325-331
5. Floderus Y, Book JA, Wetterburg L: Erythrocyte catechol-O-methyltransferase activity in related families with schizophrenia. Clin Genet 1981; 19:386-389
6. Lewander T, Von Pongracz G, Backstrom M, Wetterburg L: Dopamine metabolism in red blood cells in schizophrenia. Clin Genet 1981; 19:410-413
7. Baron M, Gruen R, Levitt M, Hunter C, Asnis L: Erythrocyte carechol O-methyltransferase activity in schizophrenia: analysis of family data. Am J Psychiatry 1984; 141:29-32
8. Eberhard G, Ross S, Saaf J, Walhund B, Wetterburg L: Psychoses in twins: a 10-year clinical and biochemical follow-up study. Schizophr Res 1989; 2:367-374
9. Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen RJ, Wilson DI, Goodship JA, Cross IE, Burn J: Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992; 339: 1138-1139
10. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW: Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 1992; 42:141-142
11. Pulver AE, Nastadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyneic MA, Morrow B, Karayiorgou M, Antonarakis SE, Housman D, Kucherlapati R: Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994; 182:476-478
12. Grossman MH, Littrell JB, Weinstein R, Szumlanski CL, Weinshilboum RM: Identification of the possible molecular basis for inherited differences in catechol O-methyl transferase. Society for Neuroscience Abstracts 1992; 18:70
13. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J: Kinetics of human soluble and membrane-bound catechol O-methyl transferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34:4202-4210
14. McGuffin P, Farmer AE, Harvey I: A polydiagnostic application of operational criteria in studies of psychotic illness. Arch Gen Psychiatry 1991; 48:764-770
15. Wing JK, Cooper JE, Sartorius N: The Measurement and Classification of Psychiatric Symptoms: An Instructional Manual for the PSE and CATEGO Programs. New York, Cambridge University Press, 1974
16. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N: SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593
17. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. New York, Academic Press, 1988, pp 216-249